Infographic: The Projected Top-Selling Therapies of 2018

How much do analysts believe the top 10 biggest-selling drugs will earn in 2018? Our latest infographic breaks down the projections.

Related Content:

Business

Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan

Sandoz, STADA, and Samsung Bioepis Report Strong Earnings From Biosimilars

Billions in Health Care Savings Realized Through Early Generic, Biosimilar Settlements